Highlights LivaNova PLC

Equities

LIVN

GB00BYMT0J19

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
56.17 ^USD	+1.15%		+4.00%	+8.56%

Mar. 20	Sector Update: Health Care Stocks Ease Late Afternoon	MT
Mar. 20	Sector Update: Health Care Stocks Down Wednesday Afternoon	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sector Update: Health Care Stocks Ease Late Afternoon	Mar. 20	MT
Sector Update: Health Care Stocks Down Wednesday Afternoon	Mar. 20	MT
LivaNova Says Sleep Apnea Study Likely to Meet Primary Efficacy Endpoint; Shares Jump	Mar. 20	MT
LivaNova PLC Announces a Positive Predictive Outcome of Trial Success in its OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea	Mar. 20	CI
LivaNova's Q4 Adjusted Earnings, Revenue Increase; Sets 2024 Guidance	Feb. 21	MT
Earnings Flash (LIVN) LIVANOVA Reports Q4 Revenue $310.1M, vs. Street Est of $287.7M	Feb. 21	MT
Earnings Flash (LIVN) LIVANOVA Reports Q4 EPS $0.87, vs. Street Est of $0.77	Feb. 21	MT
LivaNova PLC Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 21	CI
Livanova plc Provides Earnings Guidance for the Full-Year 2024	Feb. 21	CI
LivaNova PLC Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 21	CI
LivaNova Q3 Adjusted Earnings, Net Revenue Rise; Full-Year 2023 Outlook Lifted	Nov. 01	MT
Earnings Flash (LIVN) LIVANOVA Reports Q3 Revenue $286.1M, vs. Street Est of $271.9M	Nov. 01	MT
Earnings Flash (LIVN) LIVANOVA Posts Q3 EPS $0.73, vs. Street Est of $0.64	Nov. 01	MT
LIVANOVA PLC - SEES FY ADJUSTED DILUTED EARNINGS PER SHARE RANGE…	Nov. 01	RE
LIVANOVA PLC - EXPECTS REVENUE FOR FULL-YEAR 2023 TO GROW BETWEE…	Nov. 01	RE
LivaNova PLC Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 01	CI
Livanova plc Provides Revenue Guidance for the Full-Year 2023	Nov. 01	CI
LivaNova's Essenz In-Line Blood Monitor Gets US FDA Clearance, CE Mark	23-08-30	MT
LivaNova Unveils Essenz In-Line Blood Monitor with U.S. FDA 510(k) Clearance and CE Mark	23-08-30	CI
LivaNova Q2 Adjusted Earnings, Revenue Increase	23-07-26	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights LivaNova PLC

Equities

LIVN

GB00BYMT0J19

Highlights

Filters